Viatris (VTRS)
(Delayed Data from NSDQ)
$11.35 USD
-0.21 (-1.82%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $11.34 -0.01 (-0.09%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth D Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
VTRS 11.35 -0.21(-1.82%)
Will VTRS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VTRS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VTRS
Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y
Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
VTRS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Seeking Clues to Viatris (VTRS) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?
Earnings Preview: Viatris (VTRS) Q2 Earnings Expected to Decline
Other News for VTRS
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
Viatris Announces Second Quarter 2024 Dividend
Viatris declares $0.12 dividend
Earnings week ahead: Disney, Duke Energy, Palantir, Shopify, Uber and more
Chris Davis' Davis Opportunity Fund 2024 Semi-Annual Review: Looking Back